A polymeric prodrug for non-invasive, real-time reporting drug release based on “turn-on” fluorescent probes

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Non-invasive monitoring of the in situ drug release in a real-time manner is crucial for the clinical cancer treatment. In this work, a polymeric prodrug, P(HPMA-co-(CPT-SS-CyN)), composed of N-(2-hydroxypropyl) methacrylamide (HPMA) and a functional monomer (a near-infrared fluorescent cyanine-amine dye (CyN) and camptothecin (CPT) linked by disulfide bond) was reported for the non-invasive and real-time reporting drug release. The cleavage of the disulfide bond intracellularly could lead to the release of free CPT as well as the blue shift of the dye (CyN conjugated polymer), enabling facile monitoring of the drug release. Moreover, the percentage of the released drug showed a linear correlation with the normalized increase in the fluorescence intensity, which can be further used for the quantification of the local drug concentration. In vitro cell study showed that the fluorescence intensity gradually increased with the prolongation of incubation time, and P(HPMA-co-(CPT-SS-CyN)) exhibited the same inhibition efficiency of tumor cell proliferation as CPT. This work may guide researchers for the precise design and development of various pharmaceutical formulations.

Original languageEnglish
Article number104649
JournalReactive and Functional Polymers
Volume154
DOIs
StatePublished - Sep 2020

Keywords

  • In situ monitoring and qualification
  • NIR imaging
  • Polymer-drug delivery system
  • Reduction-sensitivity

Fingerprint

Dive into the research topics of 'A polymeric prodrug for non-invasive, real-time reporting drug release based on “turn-on” fluorescent probes'. Together they form a unique fingerprint.

Cite this